REQUEST AN APPOINTMENT!
Interventional Cardiologist
Dr. Akshit Sharma is an interventional cardiologist at the Cardiovascular Institute of the South in Thibodaux. Dr. Sharma attended Thanjavur Medical College in India. He completed his residency in Internal Medicine at the University of Missouri-Kansas City School of Medicine in Kansas City, Missouri. He then went on to complete his cardiovascular diseases and interventional cardiology fellowships at the University of Kansas Medical Center in Kansas City, Kansas.
Dr. Sharma is board-certified in internal medicine, cardiovascular diseases, echocardiography, nuclear cardiology and interventional cardiology. He is a member of many professional societies including the American College of Physicians, the American Medical Association, the American College of Cardiology, and the Society for Cardiovascular Angiography and Interventions.
Dr. Sharma brings a wealth of cardiology expertise to the CIS team with extensive knowledge in interpreting non-invasive cardiac testing including transthoracic and transesophageal echocardiography, nuclear stress tests, exercise tests, as well as peripheral vascular imaging. Additionally, he has special interests in managing valvular heart diseases, cardiogenic shock, high risk, and complex coronary interventions including chronic total occlusions, as well as endovascular/limb salvage peripheral interventions. He is fluent in English, Hindi, Punjabi, Urdu, and Tamil languages.
Thanjavur Medical College in India
University of Missouri-Kansas City School of Medicine
University of Kansas Medical Center
Internal Medicine
Cardiovascular Disease
Echocardiography
Nuclear Cardiology
Interventional Cardiology
American College of Physicians
American Medical Association
American College of Cardiology
Society for Cardiovascular Angiography and Interventions
Privacy StatementEmployee Information© 2020 Cardiovascular Institute of the South, All Rights Reserved.
Statements on this website are for informational purposes only and are not to be construed as altering the applicable standard of care. Likewise, such statements should not be interpreted as a guarantee that prospective or current patients of CIS will achieve any particular health outcome.